As these receptor tyrosine kinases have essential roles in the development and progression of RCC, and TKIs for these receptors are used in the treatment of mRCC, skeletal muscle-derived decorin might have anti-tumor effects in mRCC. Here, NTRK1 is linked to neoplasm.